Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 23 entries
Sorted by: Best Match Show Resources per page
Evaluating nicotine levels selection and patterns of electronic cigarette use in a group of "vapers" who had achieved complete substitution of smoking.

Substance abuse : research and treatment

Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V.
PMID: 24049448
Subst Abuse. 2013 Sep 03;7:139-46. doi: 10.4137/SART.S12756. eCollection 2013.

BACKGROUND: Electronic cigarettes (ECs) are alternative-to-smoking nicotine delivery devices; consumers (commonly called vapers) use them in order to reduce or completely substitute smoking. The European Commission has released a proposal for a new Tobacco Product Directive that might reduce...

Cite
Farsalinos KE, Romagna G, Tsiapras D, et al. Evaluating nicotine levels selection and patterns of electronic cigarette use in a group of "vapers" who had achieved complete substitution of smoking. Subst Abuse. 2013;7:139-46doi: 10.4137/SART.S12756.
Farsalinos, K. E., Romagna, G., Tsiapras, D., Kyrzopoulos, S., & Voudris, V. (2013). Evaluating nicotine levels selection and patterns of electronic cigarette use in a group of "vapers" who had achieved complete substitution of smoking. Substance abuse : research and treatment, 7139-46. https://doi.org/10.4137/SART.S12756
Farsalinos, Konstantinos E, et al. "Evaluating nicotine levels selection and patterns of electronic cigarette use in a group of "vapers" who had achieved complete substitution of smoking." Substance abuse : research and treatment vol. 7 (2013): 139-46. doi: https://doi.org/10.4137/SART.S12756
Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V. Evaluating nicotine levels selection and patterns of electronic cigarette use in a group of "vapers" who had achieved complete substitution of smoking. Subst Abuse. 2013 Sep 03;7:139-46. doi: 10.4137/SART.S12756. eCollection 2013. PMID: 24049448; PMCID: PMC3772898.
Copy Download .nbib Format: NLM
Chronic idiopathic neutrophilia in a smoker, relieved after smoking cessation with the use of electronic cigarette: a case report.

Clinical medicine insights. Case reports

Farsalinos KE, Romagna G.
PMID: 23439796
Clin Med Insights Case Rep. 2013;6:15-21. doi: 10.4137/CCRep.S11175. Epub 2013 Jan 24.

INTRODUCTION: Smoking is a major risk factor for a variety of diseases. Electronic cigarettes are battery-operated devices that deliver nicotine to the lungs by evaporation of a liquid. Chronic idiopathic neutrophilia is a condition characterized by elevated white blood...

Cite
Farsalinos KE, Romagna G. Chronic idiopathic neutrophilia in a smoker, relieved after smoking cessation with the use of electronic cigarette: a case report. Clin Med Insights Case Rep. 2013;6:15-21doi: 10.4137/CCRep.S11175.
Farsalinos, K. E., & Romagna, G. (2013). Chronic idiopathic neutrophilia in a smoker, relieved after smoking cessation with the use of electronic cigarette: a case report. Clinical medicine insights. Case reports, 615-21. https://doi.org/10.4137/CCRep.S11175
Farsalinos, Konstantinos E, and Romagna, Giorgio. "Chronic idiopathic neutrophilia in a smoker, relieved after smoking cessation with the use of electronic cigarette: a case report." Clinical medicine insights. Case reports vol. 6 (2013): 15-21. doi: https://doi.org/10.4137/CCRep.S11175
Farsalinos KE, Romagna G. Chronic idiopathic neutrophilia in a smoker, relieved after smoking cessation with the use of electronic cigarette: a case report. Clin Med Insights Case Rep. 2013;6:15-21. doi: 10.4137/CCRep.S11175. Epub 2013 Jan 24. PMID: 23439796; PMCID: PMC3571762.
Copy Download .nbib Format: NLM
Harmful effects from one puff of shisha-pen vapor: methodological and interpretational problems in the risk assessment analysis.

Tobacco induced diseases

Farsalinos KE, Baeyens F.
PMID: 27390575
Tob Induc Dis. 2016 Jul 07;14:22. doi: 10.1186/s12971-016-0086-7. eCollection 2016.

With this letter we express our concerns about the applicability of the proposed Margin of Exposure analysis as a method of risk assessment for propylene glycol and glycerol exposure from a shisha-pen type electronic cigarette. The studies used to...

Cite
Farsalinos KE, Baeyens F. Harmful effects from one puff of shisha-pen vapor: methodological and interpretational problems in the risk assessment analysis. Tob Induc Dis. 2016;14:22doi: 10.1186/s12971-016-0086-7.
Farsalinos, K. E., & Baeyens, F. (2016). Harmful effects from one puff of shisha-pen vapor: methodological and interpretational problems in the risk assessment analysis. Tobacco induced diseases, 1422. https://doi.org/10.1186/s12971-016-0086-7
Farsalinos, Konstantinos E, and Baeyens, Frank. "Harmful effects from one puff of shisha-pen vapor: methodological and interpretational problems in the risk assessment analysis." Tobacco induced diseases vol. 14 (2016): 22. doi: https://doi.org/10.1186/s12971-016-0086-7
Farsalinos KE, Baeyens F. Harmful effects from one puff of shisha-pen vapor: methodological and interpretational problems in the risk assessment analysis. Tob Induc Dis. 2016 Jul 07;14:22. doi: 10.1186/s12971-016-0086-7. eCollection 2016. PMID: 27390575; PMCID: PMC4936017.
Copy Download .nbib Format: NLM
Carbonyl Emissions in E-cigarette Aerosol: A Systematic Review and Methodological Considerations.

Frontiers in physiology

Farsalinos KE, Gillman G.
PMID: 29375395
Front Physiol. 2018 Jan 11;8:1119. doi: 10.3389/fphys.2017.01119. eCollection 2017.

Carbonyl emissions from tobacco cigarettes represent a substantial health risk contributing to smoking-related morbidity and mortality. As expected, this is an important research topic for tobacco harm reduction products, in an attempt to compare the relative risk of these...

Cite
Farsalinos KE, Gillman G. Carbonyl Emissions in E-cigarette Aerosol: A Systematic Review and Methodological Considerations. Front Physiol. 2018;8:1119doi: 10.3389/fphys.2017.01119.
Farsalinos, K. E., & Gillman, G. (2017). Carbonyl Emissions in E-cigarette Aerosol: A Systematic Review and Methodological Considerations. Frontiers in physiology, 81119. https://doi.org/10.3389/fphys.2017.01119
Farsalinos, Konstantinos E, and Gillman, Gene. "Carbonyl Emissions in E-cigarette Aerosol: A Systematic Review and Methodological Considerations." Frontiers in physiology vol. 8 (2017): 1119. doi: https://doi.org/10.3389/fphys.2017.01119
Farsalinos KE, Gillman G. Carbonyl Emissions in E-cigarette Aerosol: A Systematic Review and Methodological Considerations. Front Physiol. 2018 Jan 11;8:1119. doi: 10.3389/fphys.2017.01119. eCollection 2017. PMID: 29375395; PMCID: PMC5769337.
Copy Download .nbib Format: NLM
Effects of Exposure to Tobacco Cigarette, Electronic Cigarette and Heated Tobacco Product on Adipocyte Survival and Differentiation In Vitro.

Toxics

Zagoriti Z, El Mubarak MA, Farsalinos K, Topouzis S.
PMID: 32033401
Toxics. 2020 Feb 05;8(1). doi: 10.3390/toxics8010009.

Cigarette smoking (CS) causes significant morbidity worldwide, attributed to the numerous toxicants generated by tobacco combustion. Electronic cigarettes (ECIG) and heated tobacco products (HTP) are considered alternative smoking/vaping products that deliver nicotine through an inhaled aerosol and emit fewer...

Cite
Zagoriti Z, El Mubarak MA, Farsalinos K, et al. Effects of Exposure to Tobacco Cigarette, Electronic Cigarette and Heated Tobacco Product on Adipocyte Survival and Differentiation In Vitro. Toxics. 2020;8(1)doi: 10.3390/toxics8010009.
Zagoriti, Z., El Mubarak, M. A., Farsalinos, K., & Topouzis, S. (2020). Effects of Exposure to Tobacco Cigarette, Electronic Cigarette and Heated Tobacco Product on Adipocyte Survival and Differentiation In Vitro. Toxics, 8(1), . https://doi.org/10.3390/toxics8010009
Zagoriti, Zoi, et al. "Effects of Exposure to Tobacco Cigarette, Electronic Cigarette and Heated Tobacco Product on Adipocyte Survival and Differentiation In Vitro." Toxics vol. 8,1 (2020). doi: https://doi.org/10.3390/toxics8010009
Zagoriti Z, El Mubarak MA, Farsalinos K, Topouzis S. Effects of Exposure to Tobacco Cigarette, Electronic Cigarette and Heated Tobacco Product on Adipocyte Survival and Differentiation In Vitro. Toxics. 2020 Feb 05;8(1). doi: 10.3390/toxics8010009. PMID: 32033401; PMCID: PMC7151757.
Copy Download .nbib Format: NLM
Is e-cigarette use associated with coronary heart disease and myocardial infarction? Insights from the 2016 and 2017 National Health Interview Surveys.

Therapeutic advances in chronic disease

Farsalinos KE, Polosa R, Cibella F, Niaura R.
PMID: 31632622
Ther Adv Chronic Dis. 2019 Sep 27;10:2040622319877741. doi: 10.1177/2040622319877741. eCollection 2019.

BACKGROUND: This study analyzed the National Health Interview Surveys (NHIS) of 2016 (METHODS: Surveys were examined separately and pooled. Logistic regression analysis was used, with demographics, e-cigarette use, smoking and risk factors for CHD (hypertension, hypercholesterolemia, and diabetes) being...

Cite
Farsalinos KE, Polosa R, Cibella F, et al. Is e-cigarette use associated with coronary heart disease and myocardial infarction? Insights from the 2016 and 2017 National Health Interview Surveys. Ther Adv Chronic Dis. 2019;10:2040622319877741doi: 10.1177/2040622319877741.
Farsalinos, K. E., Polosa, R., Cibella, F., & Niaura, R. (2019). Is e-cigarette use associated with coronary heart disease and myocardial infarction? Insights from the 2016 and 2017 National Health Interview Surveys. Therapeutic advances in chronic disease, 102040622319877741. https://doi.org/10.1177/2040622319877741
Farsalinos, Konstantinos E, et al. "Is e-cigarette use associated with coronary heart disease and myocardial infarction? Insights from the 2016 and 2017 National Health Interview Surveys." Therapeutic advances in chronic disease vol. 10 (2019): 2040622319877741. doi: https://doi.org/10.1177/2040622319877741
Farsalinos KE, Polosa R, Cibella F, Niaura R. Is e-cigarette use associated with coronary heart disease and myocardial infarction? Insights from the 2016 and 2017 National Health Interview Surveys. Ther Adv Chronic Dis. 2019 Sep 27;10:2040622319877741. doi: 10.1177/2040622319877741. eCollection 2019. PMID: 31632622; PMCID: PMC6767743.
Copy Download .nbib Format: NLM
Improved strategies to counter the COVID-19 pandemic: Lockdowns vs. primary and community healthcare.

Toxicology reports

Farsalinos K, Poulas K, Kouretas D, Vantarakis A, Leotsinidis M, Kouvelas D, Docea AO, Kostoff R, Gerotziafas GT, Antoniou MN, Polosa R, Barbouni A, Yiakoumaki V, Giannouchos TV, Bagos PG, Lazopoulos G, Izotov BN, Tutelyan VA, Aschner M, Hartung T, Wallace HM, Carvalho F, Domingo JL, Tsatsakis A.
PMID: 33294384
Toxicol Rep. 2021;8:1-9. doi: 10.1016/j.toxrep.2020.12.001. Epub 2020 Dec 03.

COVID-19 pandemic mitigation strategies are mainly based on social distancing measures and healthcare system reinforcement. However, many countries in Europe and elsewhere implemented strict, horizontal lockdowns because of extensive viral spread in the community which challenges the capacity of...

Cite
Farsalinos K, Poulas K, Kouretas D, et al. Improved strategies to counter the COVID-19 pandemic: Lockdowns vs. primary and community healthcare. Toxicol Rep. 2020;8:1-9doi: 10.1016/j.toxrep.2020.12.001.
Farsalinos, K., Poulas, K., Kouretas, D., Vantarakis, A., Leotsinidis, M., Kouvelas, D., Docea, A. O., Kostoff, R., Gerotziafas, G. T., Antoniou, M. N., Polosa, R., Barbouni, A., Yiakoumaki, V., Giannouchos, T. V., Bagos, P. G., Lazopoulos, G., Izotov, B. N., Tutelyan, V. A., Aschner, M., Hartung, T., Wallace, H. M., Carvalho, F., Domingo, J. L., & Tsatsakis, A. (2021). Improved strategies to counter the COVID-19 pandemic: Lockdowns vs. primary and community healthcare. Toxicology reports, 81-9. https://doi.org/10.1016/j.toxrep.2020.12.001
Farsalinos, Konstantinos, et al. "Improved strategies to counter the COVID-19 pandemic: Lockdowns vs. primary and community healthcare." Toxicology reports vol. 8 (2021): 1-9. doi: https://doi.org/10.1016/j.toxrep.2020.12.001
Farsalinos K, Poulas K, Kouretas D, Vantarakis A, Leotsinidis M, Kouvelas D, Docea AO, Kostoff R, Gerotziafas GT, Antoniou MN, Polosa R, Barbouni A, Yiakoumaki V, Giannouchos TV, Bagos PG, Lazopoulos G, Izotov BN, Tutelyan VA, Aschner M, Hartung T, Wallace HM, Carvalho F, Domingo JL, Tsatsakis A. Improved strategies to counter the COVID-19 pandemic: Lockdowns vs. primary and community healthcare. Toxicol Rep. 2021;8:1-9. doi: 10.1016/j.toxrep.2020.12.001. Epub 2020 Dec 03. PMID: 33294384; PMCID: PMC7713637.
Copy Download .nbib Format: NLM
Electronic Nicotine Delivery Systems (ENDS) and Their Relevance in Oral Health.

Toxics

Isik Andrikopoulos G, Farsalinos K, Poulas K.
PMID: 31817732
Toxics. 2019 Dec 06;7(4). doi: 10.3390/toxics7040061.

The number and popularity of electronic nicotine delivery systems (ENDS) and especially e-cigarettes (e-cigs) have been increasing in the last decade. Although ENDS owe their popularity to excluding the harmful chemicals that are present in tobacco smoke, there is...

Cite
Isik Andrikopoulos G, Farsalinos K, Poulas K. Electronic Nicotine Delivery Systems (ENDS) and Their Relevance in Oral Health. Toxics. 2019;7(4)doi: 10.3390/toxics7040061.
Isik Andrikopoulos, G., Farsalinos, K., & Poulas, K. (2019). Electronic Nicotine Delivery Systems (ENDS) and Their Relevance in Oral Health. Toxics, 7(4), . https://doi.org/10.3390/toxics7040061
Isik Andrikopoulos, Gozde, et al. "Electronic Nicotine Delivery Systems (ENDS) and Their Relevance in Oral Health." Toxics vol. 7,4 (2019). doi: https://doi.org/10.3390/toxics7040061
Isik Andrikopoulos G, Farsalinos K, Poulas K. Electronic Nicotine Delivery Systems (ENDS) and Their Relevance in Oral Health. Toxics. 2019 Dec 06;7(4). doi: 10.3390/toxics7040061. PMID: 31817732; PMCID: PMC6958319.
Copy Download .nbib Format: NLM
E-cigarette Use and Myocardial Infarction: Association Versus Causal Inference.

American journal of preventive medicine

Farsalinos K, Niaura R.
PMID: 30898223
Am J Prev Med. 2019 Apr;56(4):626-627. doi: 10.1016/j.amepre.2018.11.013.

No abstract available.

Cite
Farsalinos K, Niaura R. E-cigarette Use and Myocardial Infarction: Association Versus Causal Inference. Am J Prev Med. 2019;56(4):626-627doi: 10.1016/j.amepre.2018.11.013.
Farsalinos, K., & Niaura, R. (2019). E-cigarette Use and Myocardial Infarction: Association Versus Causal Inference. American journal of preventive medicine, 56(4), 626-627. https://doi.org/10.1016/j.amepre.2018.11.013
Farsalinos, Konstantinos, and Niaura, Raymond. "E-cigarette Use and Myocardial Infarction: Association Versus Causal Inference." American journal of preventive medicine vol. 56,4 (2019): 626-627. doi: https://doi.org/10.1016/j.amepre.2018.11.013
Farsalinos K, Niaura R. E-cigarette Use and Myocardial Infarction: Association Versus Causal Inference. Am J Prev Med. 2019 Apr;56(4):626-627. doi: 10.1016/j.amepre.2018.11.013. PMID: 30898223.
Copy Download .nbib Format: NLM
Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review.

Therapeutic advances in drug safety

Farsalinos KE, Polosa R.
PMID: 25083263
Ther Adv Drug Saf. 2014 Apr;5(2):67-86. doi: 10.1177/2042098614524430.

Electronic cigarettes are a recent development in tobacco harm reduction. They are marketed as less harmful alternatives to smoking. Awareness and use of these devices has grown exponentially in recent years, with millions of people currently using them. This...

Cite
Farsalinos KE, Polosa R. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Ther Adv Drug Saf. 2014;5(2):67-86doi: 10.1177/2042098614524430.
Farsalinos, K. E., & Polosa, R. (2014). Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Therapeutic advances in drug safety, 5(2), 67-86. https://doi.org/10.1177/2042098614524430
Farsalinos, Konstantinos E, and Polosa, Riccardo. "Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review." Therapeutic advances in drug safety vol. 5,2 (2014): 67-86. doi: https://doi.org/10.1177/2042098614524430
Farsalinos KE, Polosa R. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Ther Adv Drug Saf. 2014 Apr;5(2):67-86. doi: 10.1177/2042098614524430. PMID: 25083263; PMCID: PMC4110871.
Copy Download .nbib Format: NLM
Health impact of electronic cigarettes and heated tobacco systems.

Internal and emergency medicine

Polosa R, Farsalinos K, Prisco D.
PMID: 31414334
Intern Emerg Med. 2019 Sep;14(6):817-820. doi: 10.1007/s11739-019-02167-4. Epub 2019 Aug 14.

No abstract available.

Cite
Polosa R, Farsalinos K, Prisco D. Health impact of electronic cigarettes and heated tobacco systems. Intern Emerg Med. 2019;14(6):817-820doi: 10.1007/s11739-019-02167-4.
Polosa, R., Farsalinos, K., & Prisco, D. (2019). Health impact of electronic cigarettes and heated tobacco systems. Internal and emergency medicine, 14(6), 817-820. https://doi.org/10.1007/s11739-019-02167-4
Polosa, Riccardo, et al. "Health impact of electronic cigarettes and heated tobacco systems." Internal and emergency medicine vol. 14,6 (2019): 817-820. doi: https://doi.org/10.1007/s11739-019-02167-4
Polosa R, Farsalinos K, Prisco D. Health impact of electronic cigarettes and heated tobacco systems. Intern Emerg Med. 2019 Sep;14(6):817-820. doi: 10.1007/s11739-019-02167-4. Epub 2019 Aug 14. PMID: 31414334.
Copy Download .nbib Format: NLM
Response to McMahon et al's "Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of four hundred fourteen cases".

Journal of the American Academy of Dermatology

Poulas K, Farsalinos K.
PMID: 34801633
J Am Acad Dermatol. 2021 Nov 18; doi: 10.1016/j.jaad.2021.09.071. Epub 2021 Nov 18.

No abstract available.

Cite
Poulas K, Farsalinos K. Response to McMahon et al's "Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of four hundred fourteen cases". J Am Acad Dermatol. 2021;doi: 10.1016/j.jaad.2021.09.071.
Poulas, K., & Farsalinos, K. (2021). Response to McMahon et al's "Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of four hundred fourteen cases". Journal of the American Academy of Dermatology, . https://doi.org/10.1016/j.jaad.2021.09.071
Poulas, Konstantinos, and Farsalinos, Konstantinos. "Response to McMahon et al's "Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of four hundred fourteen cases"." Journal of the American Academy of Dermatology vol. (2021). doi: https://doi.org/10.1016/j.jaad.2021.09.071
Poulas K, Farsalinos K. Response to McMahon et al's "Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of four hundred fourteen cases". J Am Acad Dermatol. 2021 Nov 18; doi: 10.1016/j.jaad.2021.09.071. Epub 2021 Nov 18. PMID: 34801633; PMCID: PMC8600750.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 23 entries